EMEA-002121-PIP03-19-M01
Key facts
Invented name |
Quviviq
|
Active substance |
Daridorexant
|
Therapeutic area |
Psychiatry
|
Decision number |
P/0116/2022
|
PIP number |
EMEA-002121-PIP03-19-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of insomnia
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Idorsia Pharmaceuticals Deutschland GmbH
Tel. +41 588440000 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|